COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,198 Articles (22,713 medRxiv, 8,485 bioRxiv)

Most recent first Previous |  Page 848: Articles 8471-8480  | Next

A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
Johnston, S. C., Ricks, K. M., Lakhal-Naouar, I., Jay, A., Subra, C., Raymond, J. L., King, H. A. D., Rossi, F., Clements, T. L., Fetterer, D., Tostenson, S., Cincotta, C. M., Hack, H. R., Kuklis, C., Soman, S., King, J., Peachman, K. K., Kim, D., Chen, W.-H., Sankhala, R. S., Martinez, E. J., Hajduczki, A., Chang, W. C., Choe, M., Thomas, P. V., Peterson, C. E., Anderson, A., Swafford, I., Currier, J. R., Paquin-Proulx, D., Jagodzinski, L. L., Matyas, G. R., Rao, M., Gromowski, G. D., Peel, S. A., White, L., Smith, J. M., Hooper, J. W., Michael, N. L. L., Modjarrad, K., Joyce, M. G., Nalca, A., Bolton, D. L., Pitt, M. L.
10.1101/2022.03.25.485832 — Posted: 2022-03-28
The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.
Enguita, F. J., Leitao, A. L., McDonald, J. T., Zaksas, V., Das, S., Galeano, D., Taylor, D., Syrkin Wurtele, E., Saravia-Butler, A., Baylin, S. B., Meller, R., Porterfield, D. M., Wallace, D. C., Schisler, J. C., Mason, C. E., Beheshti, A.
10.1101/2022.03.26.485903 — Posted: 2022-03-28
Genetically engineered MRI-trackable extracellular vesicles as SARS-CoV-2 mimetics for mapping ACE2 binding in vivo
Galisova, A., Zahradnik, J., Allouche-Arnon, H., Morandi, M. I., Abou Karam, P., Avinoam, O., Regev-Rudzki, N., Schreiber, G., Bar-Shir, A.
10.1101/2022.03.27.485958 — Posted: 2022-03-28
Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
Kurhade, C., Zou, j., Xia, H., Cai, H., Yang, Q., Cutler, M. W., Cooper, D., Muik, A., Jansen, K., Xie, X., Swanson, K., Shi, P.-Y.
10.1101/2022.03.24.485633 — Posted: 2022-03-28
Multiplexed measurement of binding- and neutralizing antibodies to SARS-CoV-2 variants in 12.000 post-vaccine sera
Tran, T. T., Vaage, E. B., Mehta, A., Chopra, A., Kolderup, A., Anthi, A. K., Konig, M., Nygard, G., Lind, A., Muller, F., Nissen-Meyer, L. S. H., Magnus, P., Trogstad, L.-I. S., Mjaaland, S., Soraas, A., Midtvedt, K., Aasberg, A., Barratt-Due, A., Medhus, A. W., Hoivik, M. L., Lundin, K. E. A., Karlsen, R. F., Dahle, R., Danielsson, K., Thomassen, K. S., Birkeland Kro, G., Cox, R. J., Zhou, F., Langeland, N., Aukrust, P., Melum, E., Avitsland, T. L., Wiencke, K., Holter, J. C., Munthe, L. A., Grodeland, G., Andersen, J. T., Vaage, J. T., Lund-Johansen, F.
10.1101/2022.03.26.484261 — Posted: 2022-03-28
Engineering a Vaccine Platform using Rotavirus A to Express SARS-CoV-2 Spike Epitopes
Diebold, O., Gonzalez, V., Venditti, L., Sharp, C., Blake, R. A., Stevens, J., Caddy, S., Digard, P., Borodavka, A., Gaunt, E.
10.1101/2022.03.23.485570 — Posted: 2022-03-27
Optimized production and fluorescent labelling of SARS-CoV-2 Virus-Like-Particles to study virus assembly and entry.
Muriaux, D., Gourdelier, M., Swain, J. M., Arone, C., Mouttou, A., Bracquemond, D., Merida, P., Saffarian, S., Lyonnais, S., Favard, C.
10.1101/2022.03.23.485575 — Posted: 2022-03-27
The Envelope Protein of SARS-CoV-2 Inhibits Viral Protein Synthesis and Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)
Stephens, E. B., Henke, W., Polpitiya Arachchige, S., Waisner, H., Kalamvoki, M.
10.1101/2022.03.23.485576 — Posted: 2022-03-27
Antiviral roles of interferon regulatory factor (IRF)-1, 3 and 7 against human coronavirus infection
Xu, D., Duncan, J. K. S., Licursi, M., Gohda, J., Kawaguchi, Y., Hirasawa, K.
10.1101/2022.03.24.485591 — Posted: 2022-03-27
Inconsistent directions of change in case severity across successive SARS-CoV-2 variant waves suggests an unpredictable future
Pascall, D. J., Vink, E., Mollett, G., Blacow, R., Bulteel, N., Campbell, R., Campbell, A., Clifford, S., Davis, C., da Silva Filipe, A., Fjodorova, L., Forrest, R., Goldstein, E., Gunson, R., Haughney, J., Holden, M. T., Honour, P., Hughes, J., James, E., Lewis, T., McHugh, M., Onishi, Y., Parcell, B., Robertson, D. L., El Sakka, N., Shabaan, S., Shepherd, J. G., Smollett, K., Templeton, K., Wastnedge, E., Williams, T. C., Nyberg, T., Seaman, S. R., MacLean, O., Wilkie, C., Ray, S., The COVID-19 Genomics UK (COG-UK) consortium, , Thomson, E. C.
10.1101/2022.03.24.22272915 — Posted: 2022-03-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).